Get the Stockscreener App
21.38
5.17%
-1.165
Precipio Inc stock is traded at $21.38, with a volume of 95,130.
It is down -5.17% in the last 24 hours and down -19.82% over the past month.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
See More
Previous Close:
$22.54
Open:
$22.29
24h Volume:
95,130
Relative Volume:
1.93
Market Cap:
$38.27M
Revenue:
$25.83M
Net Income/Loss:
$-922.00K
P/E Ratio:
-41.43
EPS:
-0.5159
Net Cash Flow:
$555.00K
1W Performance:
-7.55%
1M Performance:
-19.82%
6M Performance:
-26.29%
1Y Performance:
+14.61%
1-Day Range:
$21.38
$22.50
1-Week Range:
$21.38
$23.17
52-Week Range:
$16.40
$33.63
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, NTRA, A, IDXX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
21.38 | 38.27M | 25.83M | -922.00K | 555.00K | -0.5159 |
TMO
Thermo Fisher Scientific Inc
|
690.00 | 255.13B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
229.04 | 161.01B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
393.44 | 56.71B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
172.97 | 48.77B | 7.23B | 1.41B | 1.09B | 4.979 |
IDXX
Idexx Laboratories Inc
|
560.36 | 44.15B | 4.45B | 1.10B | 1.06B | 13.59 |
Precipio Inc Stock (PRPO) Latest News
Precipio, Inc. (PRPO) stock price, news, quote and history - Yahoo Finance UK
PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now? - Zacks Investment Research
Precipio Inc (NASDAQ: PRPO) Share Price, PRPO Stock News, PRPO Share Price & Updates - kalkine.ca
The Zacks Analyst Blog Highlights Goldman Sachs, RTX, Abbott, NLI and Precipio - Yahoo Finance
(PRPO) Volatility Zones as Tactical Triggers - Stock Traders Daily
Precipio Inc. (PRPO) Peer Comparison – Compare with Others - valueresearchonline.com
Precipio Inc. (PRPO) Key Financial Ratios – Valuation, Profitability & More - Value Research
Precipio Inc. (PRPO) Slips 2.36% to $26.85 as Shares Approach Key Support ZoneCall Wall - dars.gov.et
Precipio Inc. (PRPO) Slips 2.36% to $26.85 as Shares Approach Key Support ZoneHigh Dividend Factor - careplusvn.com
Precipio Inc. (PRPO) Slips 2.36% to $26.85 as Shares Approach Key Support ZoneTechnical Analysis Picks - www.dars.gov.et
Precipio Inc. (PRPO) Slips 2.36% to $26.85 as Shares Approach Key Support ZoneHigh Dividend Factor - www.dars.gov.et
Precipio Stock Price Forecast. Should You Buy PRPO? - StockInvest.us
Precipio Inc. (PRPO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Precipio (PRPO) Results Versus Estimates: The Report Supplies Updated Headline Figures in the Available Record; Price Reaction: The Stock Ends Down 1.41% for the Current SessionTangible Book Value - siam.in
Precipio (PRPO) Results Versus Estimates: The Report Supplies Updated Headline Figures in the Available Record; Price Reaction: The Stock Ends Down 1.41% for the Current SessionPerformance Review - vinanet.vn
Precipio (PRPO) Financial Update: Available Data Shows the Latest Reported Performance under the Current Snapshot - vinanet.vn
Precipio (PRPO) Financial Update: Available Data Shows the Latest Reported Performance under the Current Snapshot; Shares Move Higher 3.47% in the Latest ReadingRevenue Recognition Risk - vinanet.vn
Precipio (PRPO) Financial Update: Available Data Shows the Latest Reported Performance under the Current Snapshot - dars.gov.et
A2Z (AZ) Earnings Reading: EPS Comes in Above Forecast; Price Move: Shares Move 0.84% Down at the CloseMargin Compression Risk - www.dars.gov.et
PRPO | Precipio, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong - TradingView
Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong - Zacks Investment Research
Precipio Stock Gains Post Q2 Earnings, Revenue Momentum Strong - The Globe and Mail
Precipio Inc (PRPO) (Q2 2026) Earnings Call Highlights: Record R - GuruFocus
Precipio (PRPO) Results Check: The Company Publishes Its Latest Results; Price Reaction: Shares Finish 1.53% Lower in the Available RecordEarnings Quality Analysis - vinanet.vn
Precipio (PRPO) Results Check: The Company Publishes Its Latest Results; Price Reaction: Shares Finish 1.53% Lower in the Available RecordEPS Consistency Score - dars.gov.et
Precipio (PRPO) Results Check: The Company Publishes Its Latest Results; Price Reaction: Shares Finish 1.53% Lower in the Available RecordEarnings Seasonality - dars.gov.et
Precipio Inc (PRPO) Stock Price, Trades & News - GuruFocus
Precipio, Inc. Q2 2026 Earnings: Revenue Beats $7.02 Million Record - Sci-Tech Today
Oriental Culture Holding (OCG) Retreats 1.75% as Shares Approach Key Support at $1.60Call Dominated - careplusvn.com
Earnings call transcript: Precipio tops $7 million in Q2 2025 as growth turns profitable - Investing.com Australia
Earnings call transcript: Precipio tops $7 million in Q2 2025 as growth turns profitable - Investing.com South Africa
Earnings call transcript: Precipio tops $7 million in Q2 2025 as growth turns profitable - Investing.com Nigeria
Earnings call transcript: Precipio tops $7 million in Q2 2025 as growth turns profitable - Investing.com India
Precipio Announces Q2-2026 Financial Results - Knoxville News Sentinel
Earnings call transcript: Precipio tops $7 million in Q2 2025 as growth turns profitable - Investing.com
Precipio Announces Q2-2026 Financial Results - markets.businessinsider.com
Precipio Announces Q2-2026 Financial Results - desmoinesregister.com
Q2 2026 Precipio Inc Earnings Call Transcript - GuruFocus
Precipio Announces Q2-2026 Financial Results - einnews.com
PRPO Looks 118.2% Overvalued on GF Value™ - GuruFocus
Precipio, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
(PRPO) Risk Channels and Responsive Allocation - Stock Traders Daily
Is Precipio Inc (PRPO) Overvalued Despite Q2 Revenue of $7M? GF Score: 51/100, Valuation Discrepancy of 118.4% - GuruFocus
Precipio Posts Record Quarterly Revenue, Returns to Positive Adjusted EBITDA - Minichart
Form 8K Precipio Inc For: 14 August By Investing.com - Investing.com Australia
Precipio Q2 Revenue Hits Record $7.0 Million, Up 22% Year Over Year - Quiver Quantitative
Form 8K Precipio Inc For: 14 August By Investing.com - Investing.com India
Form 8K Precipio Inc For: 14 August By Investing.com - Investing.com Canada
Precipio posts record Q2 revenue $7.0M, returns to positive Adjusted EBITDA - TradingView
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Precipio Inc Stock (PRPO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SANDBERG RICHARD A | Director |
May 20 '26 |
Sale |
24.89 |
2,034 |
50,632 |
8,142 |
| SANDBERG RICHARD A | Director |
May 20 '26 |
Sale |
25.00 |
500 |
12,500 |
3,900 |
| SANDBERG RICHARD A | Director |
May 19 '26 |
Sale |
24.42 |
600 |
14,652 |
4,400 |
| SANDBERG RICHARD A | Director |
May 19 '26 |
Proposed Sale |
24.85 |
4,034 |
100,245 |
0 |
| Sabet Ahmed Zaki | Chief Operating Officer |
Apr 01 '26 |
Buy |
27.93 |
19 |
531 |
1,034 |
| Sabet Ahmed Zaki | Chief Operating Officer |
Jan 02 '26 |
Buy |
23.40 |
20 |
468 |
735 |
| Sabet Ahmed Zaki | Chief Operating Officer |
Oct 01 '25 |
Buy |
19.50 |
25 |
488 |
715 |
65.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):